Search by Drug Name or NDC
NDC 00013-0132-02 Emcyt 140 mg/1 Details
Emcyt 140 mg/1
Emcyt is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is ESTRAMUSTINE PHOSPHATE SODIUM.
MedlinePlus Drug Summary
Estramustine is used to treat prostate cancer that has worsened or has spread to other parts of the body. Estramustine is in a class of medications called antimicrotubule agents. It works by stopping the growth and spread of cancer cells.
Related Packages: 00013-0132-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Estramustine
Product Information
| NDC | 00013-0132 |
|---|---|
| Product ID | 0013-0132_c92bfd1e-e378-4983-9597-21c0b4e8473a |
| Associated GPIs | 21403020100105 |
| GCN Sequence Number | 008830 |
| GCN Sequence Number Description | estramustine phosphate sodium CAPSULE 140 MG ORAL |
| HIC3 | V1E |
| HIC3 Description | STEROID ANTINEOPLASTICS |
| GCN | 38700 |
| HICL Sequence Number | 003924 |
| HICL Sequence Number Description | ESTRAMUSTINE PHOSPHATE SODIUM |
| Brand/Generic | Brand |
| Proprietary Name | Emcyt |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | estramustine phosphate sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 140 |
| Active Ingredient Units | mg/1 |
| Substance Name | ESTRAMUSTINE PHOSPHATE SODIUM |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Pharmaceutical Class | Alkylating Activity [MoA], Alkylating Drug [EPC], Estradiol [CS], Nitrogen Mustard Compounds [CS] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA018045 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00013-0132-02 (00013013202)
| NDC Package Code | 0013-0132-02 |
|---|---|
| Billing NDC | 00013013202 |
| Package | 1 BOTTLE in 1 CARTON (0013-0132-02) / 100 CAPSULE in 1 BOTTLE |
| Marketing Start Date | 1992-01-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |